eScholarship
metadata only
CC BY
Recruitment and Retention Strategies for Clinical Trials in Alzheimer’s Disease
Recruitment for clinical trials is challenging for any disease but is particularly so for Alzheimer’s disease (AD). In the past three years, our site has recruited almost 600 subjects into our AD primary prevention and treatment trials, and diagnostic studies. In this article, we describe which stra
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Problem of Alzheimer's#1193431
- Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease#1211107
- Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)#890991
- Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)#870674
- A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease#852857
Record · ID 1341235
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive